Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR

NCT01556191 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

379

Enrollment

OTHER

Sponsor class

Conditions

Stage IV Lung Cancer

Interventions

DRUG: Gefitinib
DRUG: Fulvestrant
DRUG: Erlotinib

Sponsor

Intergroupe Francophone de Cancerologie Thoracique